Semaglutide, marketed under the brand names Ozempic, Wegovy, and Rybelsus, is a GLP-1 agonist available in various forms, including weekly injections (Ozempic for diabetes and Wegovy for obesity) and daily oral tablets (Rybelsus)
Your provider may recommend: Reviewing nutrition basics (protein, fiber, hydration) Adjusting habits and activity goals Updating dosage or timing when appropriate Checking sleep and stress factors The goal is sustainable progress, not extreme restriction
For use in the treatment of depression and related conditions, we typically administer glutathione through intramuscular injections or oral liposomal GSH supplementation
Mild urine/stool color change is possible due to detox it's harmless and temporary
July 28: The FDA approved RiVive, a 3 milligram (mg) naloxone hydrochloride nasal spray manufactured by Harm Reduction Therapeutics, as the second over-the-counter (OTC) naloxone rescue option for opioid overdose
It may also affect the drug's effectiveness and safety